- Home
- OPTT vs GOVX Comparison
OPTT vs GOVX Comparison
Compare OPTT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- GOVX
- Stock Information
- Founded
- OPTT 1984
- GOVX 2001
- Country
- OPTT United States
- GOVX United States
- Employees
- OPTT N/A
- GOVX N/A
- Industry
- OPTT Electric Utilities: Central
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- OPTT Utilities
- GOVX Health Care
- Exchange
- OPTT Nasdaq
- GOVX Nasdaq
- Market Cap
- OPTT 17.2M
- GOVX 17.1M
- IPO Year
- OPTT 2007
- GOVX N/A
- Fundamental
- Price
- OPTT $0.14
- GOVX $2.43
- Analyst Decision
- OPTT
- GOVX Strong Buy
- Analyst Count
- OPTT 0
- GOVX 5
- Target Price
- OPTT N/A
- GOVX $14.20
- AVG Volume (30 Days)
- OPTT 2.1M
- GOVX 3.6M
- Earning Date
- OPTT 12-11-2024
- GOVX 11-12-2024
- Dividend Yield
- OPTT N/A
- GOVX N/A
- EPS Growth
- OPTT N/A
- GOVX N/A
- EPS
- OPTT N/A
- GOVX N/A
- Revenue
- OPTT $5,554,000.00
- GOVX $3,090,161.00
- Revenue This Year
- OPTT N/A
- GOVX N/A
- Revenue Next Year
- OPTT N/A
- GOVX $565.58
- P/E Ratio
- OPTT N/A
- GOVX N/A
- Revenue Growth
- OPTT 68.81
- GOVX N/A
- 52 Week Low
- OPTT $0.12
- GOVX $1.09
- 52 Week High
- OPTT $0.57
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- OPTT 34.15
- GOVX 51.87
- Support Level
- OPTT $0.14
- GOVX $2.31
- Resistance Level
- OPTT $0.16
- GOVX $3.88
- Average True Range (ATR)
- OPTT 0.01
- GOVX 0.32
- MACD
- OPTT 0.00
- GOVX 0.10
- Stochastic Oscillator
- OPTT 0.50
- GOVX 31.92
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.